Halozyme Therapeutics (HALO) Appoints Moni Miyashita to its Board

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of Moni Miyashita to its board of directors. Ms. Miyashita is an accomplished executive with over 25 years of global strategic, mergers & acquisitions and business transformation expertise.

"We are delighted to welcome an executive with Moni's broad experience and strategic vision to the Halozyme board," said Dr. Helen Torley, president and chief executive officer. "Moni's deep experience in corporate strategy, mergers & acquisitions and risk management across multiple industries strongly complements our board's expertise as we focus on expanding and extending the growth opportunities for Halozyme."

Ms. Miyashita serves as the Chief Strategy Officer of Valo Health, LLC, a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence-anchored computation. Prior to Valo Health, as a Partner at Innosight Consulting and as a Senior Advisor at McKinsey, Ms. Miyashita provided growth strategy and M&A transaction and integration consulting services to senior executives for businesses in the biotech, healthcare and technology industries. Prior to McKinsey, Ms. Miyashita served as Vice President, Corporate Development at IBM Corporation, an information technology company where she was involved in more than 100 acquisitions.

"Halozyme's leadership role in bringing disruptive solutions to patients coupled with its exciting growth prospects makes this an exciting time to join the board of directors," said Moni Miyashita. "I look forward to working with the leadership and board members to expand Halozyme's growth opportunities and help achieve their strategic objectives."

Ms. Miyashita received her B.S. degree in marketing from the University of Colorado and her M.B.A. from the University of Denver.

You May Also Be Interested In

• Halozyme adds biotech executive Appelhans to its board
• Nuvectis Pharma (NVCT) files $200M mixed shelf
• Elroy Air wins $46M U.S. Army contract for cargo drone system